Endocan as a Marker of Endotheliitis in Covid-19 Patients: Modulation by Veno-Venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-Angiotensin-Aldosterone System Inhibitors
                        AuthID
P-017-YSZ
                
    P-017-YSZ
 
    
                     
    
                     
    
                     
    
                     
                    